Friday 6 November 2026 Export CDNA’s income statement to Excel — free account

CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024.

Revenue: +39.3%
EPS: +1,133.3%
Free cash flow: −68.6%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

76.96 8.90 −10.37%

Follow CDNA

Alert me

Market cap: $4.0B
P/E: 30.9×
Fwd P/E: 36.2×
Dividend yield: —
F-score: 5/9
Altman Z: 4.14
Beneish M: −3.36
Dividend safety: n/a

Overview

CareDx, Inc. (CDNA) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, CareDx, Inc. (CDNA) trades at a price to free cash flow of 68.9×. Over the past ten years it has ranged from 0.0× (December 2024) to 322× (December 2020); the current reading is higher than 92% of that period. That is above the Diagnostics & Research industry median of 33.5× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/CDNA/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="CareDx, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/CDNA/metrics/price-to-free-cash-flow">CareDx, Inc. (CDNA) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	29.1×	(23.70%)
FY2024	38.1×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	154×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	Price to free cash flow	Change
Sep 2026	58.2×	229.97%
Jun 2026	17.6×	25.73%
Mar 2026	14.0×	(51.71%)
Dec 2025	29.1×	35.21%
43 more quarters	Free account

Against its own ten years

Low 0.0× High 322×

Ten-year median 0.0×

Current reading's percentile 92

Company	Price to free cash flow
WGS GeneDx Holdings Corp. compare	n/m
NEO NeoGenomics, Inc. compare	n/m
GRAL GRAIL, Inc. compare	n/m
ADPT Adaptive Biotechnologies Corporation compare	n/m
VCYT Veracyte, Inc. compare	12.0×
SHC Sotera Health Company compare	33.5×
CDNA CareDx, Inc.	68.9×
BLLN BillionToOne, Inc. compare	156×
RDNT RadNet, Inc. compare	189×
Diagnostics & Research industry median	33.5×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

CareDx, Inc. (CDNA) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on CDNA

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on CDNA

Stockrow Weekly